3SBio

3SBio OCF Margin

The Operating Cash Flow Margin of 3SBio (1530.HK) as of Oct 20, 2026 is 54.64 %. In the previous year, Operating Cash Flow Margin was 35.15 % — a change of 55.46% (higher).

OCF Margin

54.64 %

YoY

55.46%

Last updated:

Operating Cash Flow Margin of 3SBio is 2025 54.64 % . Operating Cash Flow Margin of 3SBio was 2024 35.15 % . It decreases by 55.46% higher compared to the previous year.

The 3SBio OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
25.09 CNY
Jan 1, 2019
35.49 CNY
Jan 1, 2020
24.06 CNY
Jan 1, 2021
24.73 CNY
Jan 1, 2022
31.79 CNY
Jan 1, 2023
26.65 CNY
Jan 1, 2024
35.15 CNY
Jan 1, 2025
54.64 CNY
The 3SBio OCF Margin history
YEAROCF MarginYoY
54.64 %+55.46%
35.15 %+31.89%
26.65 %-16.16%
31.79 %+28.52%
24.73 %+2.78%
24.06 %-32.20%
35.49 %+41.43%
25.09 %-12.76%
28.76 %-19.89%
35.90 %+31.94%
27.21 %-20.40%
34.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

3SBio Stock analysis

What does 3SBio do? 3SBio Inc. is a biopharmaceutical company from China that specializes in the research, development, manufacturing, and marketing of biological products. It was founded in 1993 in Shenyang, a city in northeast China, and its headquarters are now in Beijing. 3SBio's business model is based on the development and manufacturing of biopharmaceuticals that are used to treat cancer, autoimmune diseases, and other serious illnesses. The company focuses on biological medicines such as proteins, antibodies, and peptides that are produced using genetic technology. 3SBio operates a wide range of business sectors, including the manufacturing and sale of biopharmaceutical products, the manufacturing and sale of generics and biosimilar products, and research and development in the biotechnology field. The company also has several subsidiaries and joint ventures, including 3SBio International Holding, Sunshine Guojian Pharmaceutical, and Target Pharma. A well-known product of 3SBio is erythropoietin (EPO), which is used in the treatment of anemia. The company also has a portfolio of other biopharmaceutical products that are used to treat cancer, autoimmune diseases, and other serious illnesses. The history of 3SBio goes back to 1993 when it was founded as Shenyang Sunshine Pharmaceutical. In 2001, the company was renamed "Shenyang Sunshine Pharmaceutical Co. Ltd. 3S Bio" and focused on biological therapy. In 2007, the company successfully listed on the Hong Kong Stock Exchange and received the name 3SBio. In 2013, the company was privatized and acquired by a consortium of Chinese investment companies. 3SBio has a strong presence in China and is also expanding into international markets. The company has distribution partnerships in Asia, Europe, and North America, and plans to enter more markets. Overall, 3SBio is a leading company in China in the field of biopharmaceuticals that focuses on the treatment of serious illnesses. The company aims to be a leader in research and development, as well as in the manufacturing and sale of innovative products, and to expand its presence in global markets. 3SBio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 3SBio stock

Operating Cash Flow Margin of 3SBio is 54.64 % in 2025.

Operating Cash Flow Margin of 3SBio changed from 35.15 % to 54.64 %, representing a 55.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin 3SBio since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's 3SBio with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — 3SBio

All Key Metrics — 3SBio